Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1751641000168117 | boric acid + calcium + colecalciferol + magnesium citrate nonahydrate + magnesium oxide heavy + manganese sulfate monohydrate + phytomenadione (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1751651000168115 | boric acid + calcium + colecalciferol + magnesium citrate nonahydrate + magnesium oxide heavy + manganese sulfate monohydrate + phytomenadione | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| boric acid + calcium + colecalciferol + magnesium citrate nonahydrate + magnesium oxide heavy + manganese sulfate monohydrate + phytomenadione | Is a | phytomenadione | false | Inferred relationship | Some | ||
| boric acid + calcium + colecalciferol + magnesium citrate nonahydrate + magnesium oxide heavy + manganese sulfate monohydrate + phytomenadione | Is a | calcium + colecalciferol | false | Inferred relationship | Some | ||
| boric acid + calcium + colecalciferol + magnesium citrate nonahydrate + magnesium oxide heavy + manganese sulfate monohydrate + phytomenadione | has intended active ingredient | calcium | false | Inferred relationship | Some | ||
| boric acid + calcium + colecalciferol + magnesium citrate nonahydrate + magnesium oxide heavy + manganese sulfate monohydrate + phytomenadione | has intended active ingredient | colecalciferol | false | Inferred relationship | Some | ||
| boric acid + calcium + colecalciferol + magnesium citrate nonahydrate + magnesium oxide heavy + manganese sulfate monohydrate + phytomenadione | has intended active ingredient | boric acid | false | Inferred relationship | Some | ||
| boric acid + calcium + colecalciferol + magnesium citrate nonahydrate + magnesium oxide heavy + manganese sulfate monohydrate + phytomenadione | has intended active ingredient | magnesium oxide heavy | false | Inferred relationship | Some | ||
| boric acid + calcium + colecalciferol + magnesium citrate nonahydrate + magnesium oxide heavy + manganese sulfate monohydrate + phytomenadione | has intended active ingredient | manganese sulfate monohydrate | false | Inferred relationship | Some | ||
| boric acid + calcium + colecalciferol + magnesium citrate nonahydrate + magnesium oxide heavy + manganese sulfate monohydrate + phytomenadione | has intended active ingredient | phytomenadione | false | Inferred relationship | Some | ||
| boric acid + calcium + colecalciferol + magnesium citrate nonahydrate + magnesium oxide heavy + manganese sulfate monohydrate + phytomenadione | has intended active ingredient | magnesium citrate nonahydrate | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| boric acid 8.6 mg (boron 1.5 mg) + calcium carbonate 1.5 g (calcium 600 mg) + colecalciferol 12.5 microgram (500 units) + magnesium (as citrate nonahydrate) 21.43 mg + magnesium (as oxide heavy) 31.07 mg + manganese (as sulfate monohydrate) 2 mg + phytomenadione 100 microgram tablet | Is a | False | boric acid + calcium + colecalciferol + magnesium citrate nonahydrate + magnesium oxide heavy + manganese sulfate monohydrate + phytomenadione | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR